Reid Landes
Concepts (357)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiation-Protective Agents | 4 | 2021 | 117 | 1.240 |
Why?
| Sample Size | 3 | 2023 | 48 | 1.200 |
Why?
| Gait Disorders, Neurologic | 2 | 2023 | 36 | 1.030 |
Why?
| Reward | 10 | 2013 | 123 | 0.960 |
Why?
| Parkinson Disease | 2 | 2023 | 178 | 0.910 |
Why?
| Smoking | 8 | 2015 | 556 | 0.890 |
Why?
| Radiation Injuries | 2 | 2023 | 163 | 0.890 |
Why?
| Antipsychotic Agents | 4 | 2014 | 246 | 0.890 |
Why?
| Impulsive Behavior | 9 | 2015 | 82 | 0.870 |
Why?
| Opioid-Related Disorders | 6 | 2023 | 365 | 0.850 |
Why?
| Heart Diseases | 1 | 2023 | 238 | 0.760 |
Why?
| Research Design | 4 | 2018 | 374 | 0.760 |
Why?
| Heart | 7 | 2023 | 364 | 0.750 |
Why?
| Models, Psychological | 3 | 2017 | 89 | 0.710 |
Why?
| Health Services Needs and Demand | 1 | 2020 | 189 | 0.680 |
Why?
| Oxygen | 5 | 2023 | 358 | 0.670 |
Why?
| Toxicology | 1 | 2018 | 32 | 0.660 |
Why?
| Clinical Trials as Topic | 2 | 2020 | 489 | 0.660 |
Why?
| Tobacco Use Disorder | 7 | 2015 | 184 | 0.620 |
Why?
| Humans | 61 | 2023 | 54132 | 0.580 |
Why?
| Protons | 3 | 2023 | 81 | 0.560 |
Why?
| Radiation Protection | 2 | 2013 | 56 | 0.550 |
Why?
| Male | 51 | 2023 | 27350 | 0.520 |
Why?
| Confidence Intervals | 3 | 2013 | 167 | 0.520 |
Why?
| Social Behavior | 2 | 2012 | 85 | 0.510 |
Why?
| Heart Defects, Congenital | 1 | 2020 | 609 | 0.500 |
Why?
| Drug Evaluation, Preclinical | 2 | 2012 | 158 | 0.490 |
Why?
| Animal Welfare | 1 | 2013 | 9 | 0.480 |
Why?
| Animals | 21 | 2023 | 14435 | 0.480 |
Why?
| Amphetamine-Related Disorders | 2 | 2012 | 125 | 0.480 |
Why?
| Methamphetamine | 3 | 2012 | 233 | 0.460 |
Why?
| Psychotic Disorders | 2 | 2014 | 144 | 0.460 |
Why?
| Guidelines as Topic | 1 | 2013 | 124 | 0.450 |
Why?
| Motivation | 6 | 2019 | 291 | 0.450 |
Why?
| Evidence-Based Practice | 1 | 2013 | 108 | 0.440 |
Why?
| Female | 45 | 2022 | 28437 | 0.440 |
Why?
| Cognition Disorders | 5 | 2015 | 240 | 0.440 |
Why?
| Smoking Cessation | 6 | 2015 | 314 | 0.430 |
Why?
| Cosmic Radiation | 2 | 2023 | 38 | 0.430 |
Why?
| Proportional Hazards Models | 2 | 2014 | 428 | 0.410 |
Why?
| Behavior, Addictive | 2 | 2011 | 58 | 0.410 |
Why?
| Herbicide Resistance | 1 | 2011 | 3 | 0.400 |
Why?
| Shikimic Acid | 1 | 2011 | 4 | 0.400 |
Why?
| Crops, Agricultural | 1 | 2011 | 8 | 0.400 |
Why?
| Intestine, Small | 3 | 2021 | 139 | 0.400 |
Why?
| Lethal Dose 50 | 3 | 2018 | 21 | 0.400 |
Why?
| Spectrophotometry | 1 | 2011 | 36 | 0.400 |
Why?
| Quality Improvement | 1 | 2013 | 242 | 0.400 |
Why?
| Radiation, Ionizing | 4 | 2021 | 121 | 0.400 |
Why?
| Data Interpretation, Statistical | 3 | 2013 | 177 | 0.400 |
Why?
| Probability | 4 | 2018 | 178 | 0.400 |
Why?
| Adult | 26 | 2023 | 14196 | 0.390 |
Why?
| Buprenorphine | 4 | 2023 | 130 | 0.390 |
Why?
| Substance Withdrawal Syndrome | 1 | 2012 | 178 | 0.390 |
Why?
| Radiation Injuries, Experimental | 1 | 2012 | 124 | 0.390 |
Why?
| Glycine | 1 | 2011 | 69 | 0.390 |
Why?
| Individuality | 1 | 2010 | 31 | 0.370 |
Why?
| Survival Analysis | 1 | 2012 | 739 | 0.370 |
Why?
| Cognition | 5 | 2019 | 350 | 0.360 |
Why?
| Psychometrics | 2 | 2010 | 241 | 0.360 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2011 | 376 | 0.350 |
Why?
| Computer Simulation | 3 | 2020 | 333 | 0.350 |
Why?
| Metabolic Diseases | 2 | 2023 | 43 | 0.340 |
Why?
| Dementia | 4 | 2014 | 149 | 0.340 |
Why?
| Choice Behavior | 5 | 2013 | 95 | 0.340 |
Why?
| Satiation | 1 | 2008 | 8 | 0.340 |
Why?
| Plant Extracts | 1 | 2011 | 193 | 0.330 |
Why?
| Central Nervous System Stimulants | 3 | 2008 | 255 | 0.330 |
Why?
| Young Adult | 11 | 2023 | 4320 | 0.320 |
Why?
| Nuclear Weapons | 2 | 2019 | 4 | 0.320 |
Why?
| Time Factors | 11 | 2017 | 3223 | 0.320 |
Why?
| Nicotine | 2 | 2009 | 207 | 0.310 |
Why?
| Executive Function | 3 | 2015 | 80 | 0.310 |
Why?
| Time Perception | 3 | 2017 | 30 | 0.300 |
Why?
| Quality Assurance, Health Care | 1 | 2008 | 164 | 0.300 |
Why?
| Health Behavior | 2 | 2020 | 268 | 0.300 |
Why?
| Guideline Adherence | 1 | 2008 | 146 | 0.300 |
Why?
| Schizophrenia | 1 | 2008 | 276 | 0.280 |
Why?
| Dose-Response Relationship, Radiation | 5 | 2023 | 215 | 0.280 |
Why?
| DNA Methylation | 3 | 2022 | 575 | 0.280 |
Why?
| Middle Aged | 23 | 2018 | 13094 | 0.280 |
Why?
| Levodopa | 2 | 2023 | 39 | 0.270 |
Why?
| Opiate Substitution Treatment | 3 | 2023 | 79 | 0.260 |
Why?
| Quality of Life | 2 | 2022 | 914 | 0.260 |
Why?
| Decision Making | 5 | 2015 | 290 | 0.260 |
Why?
| Exercise | 3 | 2023 | 537 | 0.250 |
Why?
| Mice | 12 | 2023 | 6436 | 0.250 |
Why?
| Gait | 2 | 2023 | 96 | 0.250 |
Why?
| Cocaine-Related Disorders | 3 | 2014 | 246 | 0.250 |
Why?
| Rats | 6 | 2023 | 3435 | 0.240 |
Why?
| Mice, Inbred C57BL | 8 | 2022 | 2021 | 0.240 |
Why?
| Biological Factors | 1 | 2023 | 13 | 0.240 |
Why?
| Anti-Asthmatic Agents | 1 | 2023 | 32 | 0.230 |
Why?
| Heart Atria | 1 | 2023 | 58 | 0.230 |
Why?
| Radiation Dosage | 4 | 2021 | 173 | 0.230 |
Why?
| Feasibility Studies | 2 | 2023 | 398 | 0.230 |
Why?
| Tai Ji | 1 | 2023 | 38 | 0.220 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 540 | 0.220 |
Why?
| Metformin | 1 | 2023 | 69 | 0.220 |
Why?
| Socioeconomic Factors | 3 | 2020 | 637 | 0.220 |
Why?
| Space Flight | 2 | 2019 | 37 | 0.220 |
Why?
| Transcranial Magnetic Stimulation | 2 | 2013 | 81 | 0.210 |
Why?
| Aged | 17 | 2019 | 10059 | 0.210 |
Why?
| Spleen | 2 | 2020 | 186 | 0.210 |
Why?
| Models, Statistical | 3 | 2013 | 259 | 0.210 |
Why?
| Dose-Response Relationship, Drug | 2 | 2018 | 1478 | 0.210 |
Why?
| Duodenum | 1 | 2021 | 38 | 0.200 |
Why?
| Lymphocytes | 1 | 2022 | 168 | 0.200 |
Why?
| Protein C | 1 | 2021 | 24 | 0.200 |
Why?
| Ions | 4 | 2023 | 38 | 0.200 |
Why?
| Jejunum | 1 | 2021 | 55 | 0.200 |
Why?
| Social Class | 2 | 2012 | 109 | 0.200 |
Why?
| Reproducibility of Results | 2 | 2023 | 1307 | 0.200 |
Why?
| Ileum | 1 | 2021 | 108 | 0.200 |
Why?
| Hospitals, Veterans | 2 | 2013 | 126 | 0.200 |
Why?
| Bayes Theorem | 2 | 2018 | 122 | 0.190 |
Why?
| Odds Ratio | 3 | 2018 | 603 | 0.190 |
Why?
| Weightlessness Simulation | 1 | 2020 | 24 | 0.190 |
Why?
| Survivors | 2 | 2019 | 135 | 0.190 |
Why?
| Chromosome Aberrations | 1 | 2022 | 315 | 0.190 |
Why?
| Thymus Gland | 1 | 2020 | 45 | 0.190 |
Why?
| Gamma Rays | 1 | 2020 | 58 | 0.190 |
Why?
| Amitriptyline | 1 | 2020 | 17 | 0.190 |
Why?
| Home Care Agencies | 1 | 2020 | 5 | 0.190 |
Why?
| Aorta, Abdominal | 1 | 2020 | 45 | 0.180 |
Why?
| Fibromyalgia | 1 | 2020 | 18 | 0.180 |
Why?
| Psychological Tests | 2 | 2017 | 54 | 0.180 |
Why?
| Healthcare Disparities | 2 | 2014 | 267 | 0.180 |
Why?
| Asthma | 1 | 2023 | 293 | 0.180 |
Why?
| Monte Carlo Method | 1 | 2020 | 99 | 0.180 |
Why?
| Insulin Resistance | 1 | 2022 | 316 | 0.180 |
Why?
| Aged, 80 and over | 11 | 2019 | 3442 | 0.180 |
Why?
| Adolescent | 10 | 2023 | 6890 | 0.180 |
Why?
| Quality Indicators, Health Care | 1 | 2020 | 99 | 0.170 |
Why?
| Oxygen Radioisotopes | 1 | 2019 | 16 | 0.170 |
Why?
| Adaptation, Psychological | 1 | 2020 | 244 | 0.170 |
Why?
| Phenotype | 1 | 2022 | 822 | 0.170 |
Why?
| Home Care Services | 1 | 2020 | 79 | 0.170 |
Why?
| Arkansas | 8 | 2022 | 2103 | 0.170 |
Why?
| Thigh | 1 | 2018 | 39 | 0.170 |
Why?
| Analysis of Variance | 2 | 2017 | 642 | 0.160 |
Why?
| User-Computer Interface | 1 | 2018 | 93 | 0.160 |
Why?
| Weight Gain | 2 | 2022 | 244 | 0.160 |
Why?
| Cardiovascular Diseases | 1 | 2023 | 482 | 0.160 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2018 | 121 | 0.160 |
Why?
| Skin | 1 | 2021 | 469 | 0.150 |
Why?
| Long Interspersed Nucleotide Elements | 1 | 2017 | 41 | 0.150 |
Why?
| Intention | 1 | 2017 | 43 | 0.150 |
Why?
| Drug Monitoring | 2 | 2014 | 85 | 0.150 |
Why?
| Gene Expression | 2 | 2019 | 667 | 0.150 |
Why?
| Directive Counseling | 2 | 2014 | 24 | 0.150 |
Why?
| Whole-Body Irradiation | 2 | 2021 | 160 | 0.150 |
Why?
| Telephone | 2 | 2014 | 74 | 0.140 |
Why?
| Random Allocation | 1 | 2017 | 315 | 0.140 |
Why?
| Myocardium | 1 | 2019 | 445 | 0.140 |
Why?
| Universities | 1 | 2017 | 164 | 0.140 |
Why?
| United States | 5 | 2020 | 5172 | 0.140 |
Why?
| Tomography, X-Ray Computed | 2 | 2019 | 1210 | 0.140 |
Why?
| Depressive Disorder | 2 | 2009 | 367 | 0.140 |
Why?
| Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 21 | 0.140 |
Why?
| Gene Duplication | 1 | 2015 | 17 | 0.140 |
Why?
| Hematopoietic Stem Cells | 1 | 2017 | 215 | 0.130 |
Why?
| Body Weight | 2 | 2020 | 583 | 0.130 |
Why?
| Green Fluorescent Proteins | 1 | 2015 | 110 | 0.130 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2015 | 42 | 0.130 |
Why?
| Students | 1 | 2017 | 207 | 0.130 |
Why?
| Hyperlipidemias | 1 | 2014 | 51 | 0.120 |
Why?
| Conditioning, Operant | 1 | 2015 | 106 | 0.120 |
Why?
| Educational Status | 4 | 2015 | 254 | 0.120 |
Why?
| Hyperglycemia | 1 | 2014 | 86 | 0.120 |
Why?
| Biofeedback, Psychology | 1 | 2013 | 16 | 0.120 |
Why?
| Liver | 3 | 2023 | 1246 | 0.120 |
Why?
| Databases, Factual | 2 | 2013 | 685 | 0.120 |
Why?
| Electric Stimulation | 1 | 2013 | 93 | 0.120 |
Why?
| Alzheimer Disease | 2 | 2009 | 365 | 0.120 |
Why?
| Medical Records | 1 | 2013 | 92 | 0.120 |
Why?
| Eye Diseases | 1 | 2013 | 35 | 0.110 |
Why?
| Sexual Behavior | 1 | 2014 | 125 | 0.110 |
Why?
| Cluster Analysis | 1 | 2013 | 250 | 0.110 |
Why?
| Physicians, Primary Care | 1 | 2013 | 43 | 0.110 |
Why?
| Cholesterol, LDL | 1 | 2013 | 41 | 0.110 |
Why?
| Japan | 3 | 2019 | 25 | 0.110 |
Why?
| Diabetes Complications | 1 | 2013 | 124 | 0.110 |
Why?
| Pain | 2 | 2023 | 400 | 0.110 |
Why?
| Sex Characteristics | 1 | 2014 | 217 | 0.110 |
Why?
| Animal Experimentation | 1 | 2012 | 5 | 0.110 |
Why?
| Internal-External Control | 1 | 2012 | 37 | 0.110 |
Why?
| Qualitative Research | 1 | 2013 | 331 | 0.100 |
Why?
| Internet | 1 | 2014 | 274 | 0.100 |
Why?
| Psychiatric Status Rating Scales | 2 | 2014 | 347 | 0.100 |
Why?
| Aggression | 2 | 2011 | 60 | 0.100 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 233 | 0.100 |
Why?
| Community Networks | 1 | 2012 | 54 | 0.100 |
Why?
| Commodification | 1 | 2011 | 2 | 0.100 |
Why?
| Herbicides | 1 | 2011 | 14 | 0.100 |
Why?
| Receptors, Steroid | 1 | 2010 | 25 | 0.100 |
Why?
| Treatment Outcome | 7 | 2018 | 5596 | 0.100 |
Why?
| Veterans | 2 | 2018 | 628 | 0.100 |
Why?
| Education | 1 | 2010 | 47 | 0.100 |
Why?
| Adolescent Behavior | 1 | 2011 | 113 | 0.100 |
Why?
| Psychomotor Agitation | 1 | 2011 | 53 | 0.100 |
Why?
| Kaplan-Meier Estimate | 1 | 2012 | 514 | 0.090 |
Why?
| Cytochrome P-450 CYP3A | 1 | 2010 | 82 | 0.090 |
Why?
| Meta-Analysis as Topic | 1 | 2010 | 40 | 0.090 |
Why?
| Memory, Short-Term | 1 | 2010 | 85 | 0.090 |
Why?
| Clinical Competence | 1 | 2013 | 447 | 0.090 |
Why?
| Marijuana Abuse | 1 | 2011 | 149 | 0.090 |
Why?
| Blood Glucose | 1 | 2013 | 491 | 0.090 |
Why?
| Attitude of Health Personnel | 1 | 2013 | 397 | 0.090 |
Why?
| Extinction, Psychological | 1 | 2009 | 26 | 0.090 |
Why?
| Apolipoprotein E4 | 1 | 2009 | 19 | 0.090 |
Why?
| Antibodies, Monoclonal | 2 | 2005 | 560 | 0.090 |
Why?
| Diphenhydramine | 1 | 2009 | 20 | 0.090 |
Why?
| Anesthesia, Local | 1 | 2009 | 19 | 0.090 |
Why?
| Ophthalmic Solutions | 1 | 2009 | 27 | 0.090 |
Why?
| Soybean Proteins | 1 | 2010 | 152 | 0.090 |
Why?
| Logistic Models | 4 | 2014 | 991 | 0.090 |
Why?
| Aging | 1 | 2015 | 786 | 0.090 |
Why?
| Cornea | 1 | 2009 | 62 | 0.080 |
Why?
| Epigenesis, Genetic | 2 | 2022 | 399 | 0.080 |
Why?
| Mutation | 1 | 2015 | 1499 | 0.080 |
Why?
| Anesthetics, Local | 1 | 2009 | 74 | 0.080 |
Why?
| Multivariate Analysis | 3 | 2017 | 646 | 0.080 |
Why?
| Dexamethasone | 1 | 2010 | 448 | 0.080 |
Why?
| Analgesics, Opioid | 3 | 2023 | 497 | 0.080 |
Why?
| Promoter Regions, Genetic | 1 | 2010 | 526 | 0.080 |
Why?
| Health Care Surveys | 1 | 2008 | 194 | 0.080 |
Why?
| Analgesics | 1 | 2008 | 106 | 0.070 |
Why?
| Models, Biological | 1 | 2011 | 824 | 0.070 |
Why?
| Child | 4 | 2023 | 7312 | 0.070 |
Why?
| Mental Competency | 1 | 2007 | 33 | 0.070 |
Why?
| Rabbits | 2 | 2023 | 440 | 0.070 |
Why?
| Informed Consent | 1 | 2007 | 92 | 0.070 |
Why?
| Cross-Sectional Studies | 3 | 2017 | 1678 | 0.070 |
Why?
| Sex Factors | 3 | 2015 | 770 | 0.070 |
Why?
| Antibody Affinity | 1 | 2005 | 11 | 0.070 |
Why?
| Practice Guidelines as Topic | 1 | 2008 | 491 | 0.060 |
Why?
| Activities of Daily Living | 2 | 2020 | 204 | 0.060 |
Why?
| Neuropsychological Tests | 3 | 2011 | 363 | 0.060 |
Why?
| Single-Blind Method | 2 | 2013 | 124 | 0.060 |
Why?
| Adrenal Cortex Hormones | 1 | 2023 | 96 | 0.060 |
Why?
| Mental Disorders | 1 | 2008 | 451 | 0.060 |
Why?
| Longitudinal Studies | 2 | 2015 | 743 | 0.060 |
Why?
| Prefrontal Cortex | 2 | 2013 | 89 | 0.060 |
Why?
| Token Economy | 2 | 2014 | 33 | 0.060 |
Why?
| Cytogenetic Analysis | 1 | 2022 | 89 | 0.050 |
Why?
| Methadone | 1 | 2023 | 169 | 0.050 |
Why?
| Combined Modality Therapy | 2 | 2014 | 694 | 0.050 |
Why?
| Leukocytes, Mononuclear | 1 | 2022 | 133 | 0.050 |
Why?
| Primates | 1 | 2021 | 20 | 0.050 |
Why?
| Risk Factors | 3 | 2019 | 3936 | 0.050 |
Why?
| Macaca mulatta | 1 | 2021 | 105 | 0.050 |
Why?
| Immunoblotting | 1 | 2021 | 134 | 0.050 |
Why?
| Overweight | 1 | 2023 | 230 | 0.050 |
Why?
| Chromans | 1 | 2021 | 63 | 0.050 |
Why?
| Catecholamines | 1 | 2020 | 48 | 0.050 |
Why?
| Rats, Long-Evans | 1 | 2020 | 29 | 0.050 |
Why?
| Interviews as Topic | 2 | 2012 | 318 | 0.050 |
Why?
| Disease Progression | 1 | 2023 | 915 | 0.050 |
Why?
| Vitamin E | 1 | 2021 | 108 | 0.050 |
Why?
| Drinking | 1 | 2020 | 78 | 0.050 |
Why?
| Policy | 1 | 2020 | 27 | 0.050 |
Why?
| Area Under Curve | 2 | 2015 | 205 | 0.050 |
Why?
| Intestines | 1 | 2021 | 206 | 0.040 |
Why?
| DNA, Satellite | 1 | 2019 | 15 | 0.040 |
Why?
| Centromere | 1 | 2019 | 16 | 0.040 |
Why?
| Genotype | 1 | 2021 | 607 | 0.040 |
Why?
| Intestinal Mucosa | 1 | 2021 | 274 | 0.040 |
Why?
| Retrospective Studies | 3 | 2020 | 6387 | 0.040 |
Why?
| Energy Intake | 1 | 2020 | 197 | 0.040 |
Why?
| Insulin | 1 | 2022 | 520 | 0.040 |
Why?
| Heart Rate | 1 | 2021 | 353 | 0.040 |
Why?
| Age Factors | 2 | 2015 | 1198 | 0.040 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 92 | 0.040 |
Why?
| Stress, Physiological | 1 | 2020 | 194 | 0.040 |
Why?
| Carbon | 1 | 2019 | 59 | 0.040 |
Why?
| Metabolic Networks and Pathways | 1 | 2019 | 105 | 0.040 |
Why?
| Rats, Sprague-Dawley | 3 | 2010 | 1676 | 0.040 |
Why?
| Medicare | 1 | 2020 | 233 | 0.040 |
Why?
| Methionine | 1 | 2019 | 147 | 0.040 |
Why?
| Organ Size | 1 | 2018 | 245 | 0.040 |
Why?
| Immunohistochemistry | 1 | 2021 | 1097 | 0.040 |
Why?
| Psychological Theory | 1 | 2017 | 25 | 0.040 |
Why?
| Retroelements | 1 | 2017 | 15 | 0.040 |
Why?
| Mice, Inbred CBA | 1 | 2017 | 39 | 0.040 |
Why?
| Emotions | 1 | 2019 | 163 | 0.040 |
Why?
| Resistance Training | 1 | 2018 | 102 | 0.040 |
Why?
| Hematopoiesis | 1 | 2017 | 80 | 0.040 |
Why?
| Species Specificity | 1 | 2017 | 207 | 0.040 |
Why?
| Adipose Tissue | 1 | 2018 | 230 | 0.040 |
Why?
| Gene Knock-In Techniques | 1 | 2015 | 31 | 0.030 |
Why?
| Genes | 1 | 2015 | 38 | 0.030 |
Why?
| Exons | 1 | 2015 | 105 | 0.030 |
Why?
| Age Distribution | 1 | 2015 | 199 | 0.030 |
Why?
| Pancreas | 1 | 2015 | 83 | 0.030 |
Why?
| DNA Damage | 1 | 2017 | 358 | 0.030 |
Why?
| Rural Population | 1 | 2020 | 599 | 0.030 |
Why?
| Antibody Specificity | 2 | 2005 | 47 | 0.030 |
Why?
| Bone and Bones | 1 | 2018 | 523 | 0.030 |
Why?
| Infant | 1 | 2023 | 3797 | 0.030 |
Why?
| Risk Assessment | 1 | 2019 | 1363 | 0.030 |
Why?
| Control Groups | 1 | 2013 | 10 | 0.030 |
Why?
| Narcotic Antagonists | 1 | 2014 | 127 | 0.030 |
Why?
| Mice, Inbred BALB C | 2 | 2005 | 368 | 0.030 |
Why?
| Obesity | 1 | 2022 | 1218 | 0.030 |
Why?
| Gambling | 1 | 2013 | 19 | 0.030 |
Why?
| Residence Characteristics | 1 | 2014 | 164 | 0.030 |
Why?
| United States Department of Veterans Affairs | 1 | 2014 | 315 | 0.030 |
Why?
| Ophthalmology | 1 | 2013 | 40 | 0.030 |
Why?
| Tobacco Products | 1 | 2015 | 115 | 0.030 |
Why?
| Motor Activity | 2 | 2005 | 248 | 0.030 |
Why?
| Chi-Square Distribution | 1 | 2013 | 318 | 0.030 |
Why?
| Apoptosis | 1 | 2019 | 1306 | 0.030 |
Why?
| Muscle, Skeletal | 1 | 2018 | 843 | 0.030 |
Why?
| Recurrence | 1 | 2014 | 692 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2017 | 1075 | 0.030 |
Why?
| Health Status Disparities | 1 | 2014 | 219 | 0.030 |
Why?
| Behavior Therapy | 1 | 2013 | 203 | 0.030 |
Why?
| Videotape Recording | 1 | 2011 | 30 | 0.020 |
Why?
| Referral and Consultation | 1 | 2013 | 307 | 0.020 |
Why?
| Verbal Behavior | 1 | 2011 | 35 | 0.020 |
Why?
| Noise | 1 | 2011 | 37 | 0.020 |
Why?
| Midazolam | 1 | 2010 | 42 | 0.020 |
Why?
| Homes for the Aged | 1 | 2011 | 33 | 0.020 |
Why?
| Enzyme Induction | 1 | 2010 | 80 | 0.020 |
Why?
| Response Elements | 1 | 2010 | 34 | 0.020 |
Why?
| Chromatin Immunoprecipitation | 1 | 2010 | 56 | 0.020 |
Why?
| Sex Distribution | 1 | 2011 | 158 | 0.020 |
Why?
| Caseins | 1 | 2010 | 73 | 0.020 |
Why?
| Income | 1 | 2010 | 101 | 0.020 |
Why?
| Substance Abuse Detection | 1 | 2010 | 92 | 0.020 |
Why?
| Protein Transport | 1 | 2010 | 196 | 0.020 |
Why?
| Nursing Homes | 1 | 2011 | 127 | 0.020 |
Why?
| Language | 1 | 2011 | 138 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2015 | 2384 | 0.020 |
Why?
| Nicotinic Agonists | 1 | 2009 | 60 | 0.020 |
Why?
| Self Administration | 1 | 2009 | 99 | 0.020 |
Why?
| Administration, Topical | 1 | 2009 | 72 | 0.020 |
Why?
| Secondary Prevention | 1 | 2009 | 89 | 0.020 |
Why?
| Reaction Time | 1 | 2009 | 227 | 0.020 |
Why?
| Regression Analysis | 1 | 2009 | 446 | 0.020 |
Why?
| Self Concept | 1 | 2008 | 69 | 0.020 |
Why?
| Patient Compliance | 1 | 2009 | 249 | 0.020 |
Why?
| Internship and Residency | 1 | 2013 | 498 | 0.020 |
Why?
| Audiovisual Aids | 1 | 2007 | 16 | 0.020 |
Why?
| RNA, Messenger | 1 | 2010 | 1222 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2009 | 1053 | 0.020 |
Why?
| Reading | 1 | 2007 | 84 | 0.020 |
Why?
| Prevalence | 1 | 2009 | 1023 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2008 | 1084 | 0.020 |
Why?
| Immunoglobulin G | 1 | 2005 | 228 | 0.020 |
Why?
| Behavior, Animal | 1 | 2005 | 201 | 0.020 |
Why?
| Drug Overdose | 1 | 2005 | 154 | 0.010 |
Why?
| Amphetamine | 1 | 2003 | 42 | 0.010 |
Why?
| Tissue Distribution | 1 | 2003 | 171 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2005 | 1645 | 0.010 |
Why?
| Brain | 1 | 2003 | 1364 | 0.010 |
Why?
|
|
Landes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|